Quality of Evidence:
Coadministration has not been studied but based on metabolism and clearance a clinically significant pharmacokinetic interaction is unlikely as flucloxacillin is mainly eliminated renally. However, HLA-5701 has been identified as the main genetic risk factor for flucloxacillin induced liver injury and patients should be genotyped before receiving either drug.
View all available interactions with
Abacavir (ABC) by clicking